Forms of rifaximin and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9181274
APP PUB NO 20140011828A1
SERIAL NO

13644241

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to Rifaximin amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALFA WASSERMANN S P A65020 ALANNO (PE)

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bevill, Melanie Janelle West Lafayette, US 18 111
Gushurst, Karen S West Lafayette, US 15 146
Schultheiss, Nathan Carl Lafayette, US 23 173
Viscomi, Giuseppe Claudio Bologna, IT 82 622
Yang, Donglai Annandale, US 19 142

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00